Relafen 750, also known as naproxol, represents a unique example of selective biochemical intervention within the realm of pain management . From a therapeutic perspective, its mechanism of activity copyrights upon the inhibition of cyclooxygenase (COX) enzymes , particularly COX-2, contributing to the production of pain signals. This selective act